Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Kogner

Showing results (51-60 of 168) with videos related to

Pageof 17
Sort By:
International Journal of Cancer|July 8, 2010
Birth characteristics and Wilms tumors in children in the Nordic countries: a register-based case-control studyJoachim Schüz, Lisbeth Samsø Schmidt, Per Kogner, et al.
Anticancer Research|August 8, 2009
The angiogenic growth factors HGF and VEGF in serum and plasma from neuroblastoma patientsErik G Sköldenberg, Anders Larsson, Ake Jakobson, et al.
Carcinogenesis|January 26, 2013
Low-dose aspirin delays an inflammatory tumor progression in vivo in a transgenic mouse model of neuroblastomaLena-Maria Carlson, Agnes Rasmuson, Helena Idborg, et al.
Journal of the National Cancer Institute|March 4, 2014
Protective role of humanin on bortezomib-induced bone growth impairment in anticancer treatmentEmma Eriksson, Malin Wickström, Lova Segerström Perup, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 6, 2009
Docosahexaenoic acid metabolome in neural tumors: identification of cytotoxic intermediatesHelena Gleissman, Rong Yang, Kimberly Martinod, et al.
Clinical Epigenetics|July 27, 2025
DNA methylation profiling for molecular classification of neuroblastomaMaja Löfgren, Anna Djos, Shiva Rezaei, et al.
Oncogene|April 18, 2003
Screening for gene mutations in a 500 kb neuroblastoma tumor suppressor candidate region in chromosome 1p; mutation and stage-specific expression in UBE4B/UFD2Cecilia Krona, Katarina Ejeskär, Frida Abel, et al.
BMC Genomics|July 31, 2008
High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A geneHelena Carén, Jennie Erichsen, Linda Olsson, et al.
Scientific Reports|February 20, 2019
Low Frequency ALK Hotspots Mutations In Neuroblastoma Tumours Detected By Ultra-deep Sequencing: Implications For ALK Inhibitor TreatmentNiloufar Javanmardi, Susanne Fransson, Anna Djos, et al.
Cancer Letters|June 25, 2005
NSAIDs in neuroblastoma therapyJohn I Johnsen, Magnus Lindskog, Frida Ponthan, et al.
Pageof 17

Showing results (51-60 of 168) with videos related to

Sort By:
Pageof 17
International Journal of Cancer|July 8, 2010
Birth characteristics and Wilms tumors in children in the Nordic countries: a register-based case-control studyJoachim Schüz, Lisbeth Samsø Schmidt, Per Kogner, et al.
Anticancer Research|August 8, 2009
The angiogenic growth factors HGF and VEGF in serum and plasma from neuroblastoma patientsErik G Sköldenberg, Anders Larsson, Ake Jakobson, et al.
Carcinogenesis|January 26, 2013
Low-dose aspirin delays an inflammatory tumor progression in vivo in a transgenic mouse model of neuroblastomaLena-Maria Carlson, Agnes Rasmuson, Helena Idborg, et al.
Journal of the National Cancer Institute|March 4, 2014
Protective role of humanin on bortezomib-induced bone growth impairment in anticancer treatmentEmma Eriksson, Malin Wickström, Lova Segerström Perup, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|November 6, 2009
Docosahexaenoic acid metabolome in neural tumors: identification of cytotoxic intermediatesHelena Gleissman, Rong Yang, Kimberly Martinod, et al.
Clinical Epigenetics|July 27, 2025
DNA methylation profiling for molecular classification of neuroblastomaMaja Löfgren, Anna Djos, Shiva Rezaei, et al.
Oncogene|April 18, 2003
Screening for gene mutations in a 500 kb neuroblastoma tumor suppressor candidate region in chromosome 1p; mutation and stage-specific expression in UBE4B/UFD2Cecilia Krona, Katarina Ejeskär, Frida Abel, et al.
BMC Genomics|July 31, 2008
High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors: four cases of homozygous deletions of the CDKN2A geneHelena Carén, Jennie Erichsen, Linda Olsson, et al.
Scientific Reports|February 20, 2019
Low Frequency ALK Hotspots Mutations In Neuroblastoma Tumours Detected By Ultra-deep Sequencing: Implications For ALK Inhibitor TreatmentNiloufar Javanmardi, Susanne Fransson, Anna Djos, et al.
Cancer Letters|June 25, 2005
NSAIDs in neuroblastoma therapyJohn I Johnsen, Magnus Lindskog, Frida Ponthan, et al.
Pageof 17